This page is part of the FHIR Specification (v4.4.0: R5 Preview #2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Encounter, Patient, Practitioner |
Raw XML (canonical form + also see XML Format Specification)
Request for Intravenous Chemotherapy (inpatient order) - Brentuximab Vedotin - completed (id = "medrx0316")
<?xml version="1.0" encoding="UTF-8"?> <MedicationRequest xmlns="http://hl7.org/fhir"> <id value="medrx0316"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative with Details</b> </p> <p> <b> id</b> : medrx0316</p> <p> <b> contained</b> : </p> <p> <b> identifier</b> : 12345689 (OFFICIAL)</p> <p> <b> status</b> : completed</p> <p> <b> intent</b> : order</p> <p> <b> medication</b> : </p> <p> <b> subject</b> : <a> Donald Duck</a> </p> <p> <b> encounter</b> : <a> encounter who leads to this prescription</a> </p> <p> <b> authoredOn</b> : 2015-01-15</p> <p> <b> requester</b> : <a> Patrick Pump</a> </p> <p> <b> instantiatesUri</b> : <a> http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protoc ol_1Jun2017.pdf</a> </p> <p> <b> dosageInstruction</b> : </p> </div> </text> <contained> <Medication> <id value="med0306"/> <code> <coding> <system value="http://hl7.org/fhir/sid/ndc"/> <code value="51144-050-01"/> <display value="Adcetris"/> </coding> </code> <doseForm> <coding> <system value="http://snomed.info/sct"/> <code value="421637006"/> <display value="Lyophilized powder for injectable solution (qualifier value) "/> </coding> </doseForm> <batch> <lotNumber value="12345"/> <expirationDate value="2019-10-31"/> </batch> </Medication> </contained> <identifier> <use value="official"/> <system value="http://www.bmc.nl/portal/prescriptions"/> <value value="12345689"/> </identifier> <status value="completed"/> <intent value="order"/> <medication> <!-- Linked to a RESOURCE Medication --> <reference> <reference value="#med0306"/> </reference> </medication> <subject> <!-- Linked to the resource patient who needs the medication --> <reference value="Patient/pat1"/> <display value="Donald Duck"/> </subject> <encounter> <!-- Linked to a resource Encounter between patient and practitioner --> <reference value="Encounter/f001"/> <display value="encounter who leads to this prescription"/> </encounter> <authoredOn value="2015-01-15"/> <requester> <reference value="Practitioner/f007"/> <display value="Patrick Pump"/> </requester> <instantiatesUri value="http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protoc ol_1Jun2017.pdf"/> <dosageInstruction> <sequence value="1"/> <text value="1.8 mg/kg IV infusion over 20 minutes every 3 weeks for 16 cycles"/> <timing> <repeat> <count value="16"/> <frequency value="1"/> <period value="3"/> <periodUnit value="wk"/> </repeat> </timing> <route> <coding> <system value="http://snomed.info/sct"/> <code value="255560000"/> <display value="Intravenous"/> </coding> </route> <doseAndRate> <type> <coding> <system value="http://terminology.hl7.org/CodeSystem/dose-rate-type"/> <code value="ordered"/> <display value="Ordered"/> </coding> </type> <doseQuantity> <value value="1.8"/> <unit value="mg/kg"/> <system value="http://unitsofmeasure.org"/> <code value="mg/kg"/> </doseQuantity> <rateRatio> <numerator> <value value="1.8"/> <system value="http://unitsofmeasure.org"/> <code value="mg/kg"/> </numerator> <denominator> <value value="20"/> <system value="http://unitsofmeasure.org"/> <code value="min"/> </denominator> </rateRatio> </doseAndRate> <maxDosePerLifetime> <value value="400"/> <unit value="mg"/> <system value="http://unitsofmeasure.org"/> <code value="mg"/> </maxDosePerLifetime> </dosageInstruction> </MedicationRequest>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.